Gerasimos Filippatos
National and Kapodistrian University of Athens
H-index: 161
Europe-Greece
Top articles of Gerasimos Filippatos
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF‐REVERT trial | European Journal of Heart Failure | Johann Bauersachs Scott D Solomon Stefan D Anker Isabel Antorrena‐Miranda Sandor Batkai | 2024/1/25 |
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists | Gianluigi Savarese Felix Lindberg Gerasimos Filippatos Javed Butler Stefan D Anker | 2024/2 | |
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis | Diabetes, Obesity and Metabolism | Khawaja M Talha Jennifer Green Gerasimos Filippatos Stuart Pocock Faiez Zannad | 2024/4/1 |
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm … | European journal of heart failure | Wilfried Mullens Jeroen Dauw Finn Gustafsson Alexandre Mebazaa Jan Steffel | 2024/1/25 |
Blood pressure and intensive treatment up‐titration after acute heart failure hospitalization: Insights from the STRONG‐HF trial | European Journal of Heart Failure | Matteo Pagnesi Oscar Alberto Gomez Vilamajó Alejandro Meiriño Carlos Alberto Dumont Alexandre Mebazaa | 2024/3/5 |
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and … | American Heart Journal | Gianluigi Savarese Paolo Gatti Lina Benson Marianna Adamo Ovidiu Chioncel | 2024/1/1 |
Efficacy and safety of empagliflozin according to background diuretic use in HFrEF: post-hoc analysis of EMPEROR-Reduced | Heart Failure | Nitish K Dhingra Subodh Verma Javed Butler Stefan D Anker Joao Pedro Ferreira | 2024/1/1 |
Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in EMPEROR‐Preserved | European Journal of Heart Failure | Tripti Rastogi João Pedro Ferreira Javed Butler Bettina Johanna Kraus Michaela Mattheus | 2024/1/21 |
Implementation Approaches in Heart Failure With Mildly Reduced and Preserved Ejection Fraction | Ankeet S Bhatt Gerasimos Filippatos Muthiah Vaduganathan | 2024/4/1 | |
Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial | Stem Cells Translational Medicine | Satsuki Yamada Jozef Bartunek Thomas J Povsic Gad Cotter Beth A Davison | 2024/2/1 |
The effect of sodium–glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta‐analysis | Muhammad Shariq Usman James L Januzzi Stefan D Anker Ali Salman Puja B Parikh | 2024/2 | |
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR‐Preserved analysis | European Journal of Heart Failure | João Pedro Ferreira Faiez Zannad Milton Packer Gerasimos Filippatos Stuart J Pocock | 2024/3/4 |
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis | Diabetes, Obesity and Metabolism | Nikolaos Perakakis Stefan R Bornstein Andreas L Birkenfeld Andreas Linkermann Münevver Demir | 2024/1 |
Epidemiology and risk factors for hyperkalaemia in heart failure | Diederick E Grobbee Gerasimos Filippatos Nihar R Desai Andrew JS Coats Fausto Pinto | 2024 | |
Sacubitril/valsartan compared to ramipril in high‐risk post‐myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from … | European Journal of Heart Failure | Morten Schou Brian Claggett Zi Michael Miao Alberto Fernandez Gerasimos Filippatos | 2024/1 |
Body mass index and cardiorenal outcomes in the EMPEROR‐Preserved trial: Principal findings and meta‐analysis with the DELIVER trial | European Journal of Heart Failure | Naveed Sattar Javed Butler Matthew MY Lee Josephine Harrington Abhinav Sharma | 2024/4/1 |
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials | European Journal of Heart Failure | João Pedro Ferreira Javed Butler Stefan D Anker James L Januzzi Marina Panova‐Noeva | 2023/12/1 |
Performance of Different Risk Scores for the Detection of Atrial Fibrillation Among Patients With Cryptogenic Stroke | Stroke | Lina Palaiodimou Aikaterini Theodorou Sokratis Triantafyllou Polychronis Dilaveris Panagiota Flevari | 2024/2 |
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials | BMJ open | Shweta Bansal Maria EF Canziani Rita Birne Stefan D Anker George L Bakris | 2024/3/1 |
Epidemiology, pathophysiology, diagnosis and management of chronic right‐sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure … | European journal of heart failure | Marianna Adamo Ovidiu Chioncel Matteo Pagnesi Antoni Bayes‐Genis Magdy Abdelhamid | 2024/1 |
